基于灰色综合关联分析法的粤港澳大湾区生物医药产业效益研究*

生物医药产业是中国医药制造业的第三大产业,也是粤港澳大湾区重点扶持的新兴高技术产业之一。透视产业主营业务收入与各类指标的关联情况是进一步指导粤港澳大湾区生物医药产业建设规划的必要之举。而灰色综合关联分析法是探索指标间关联程度的重要工具。通过多种权威途径获得粤港澳大湾区生物医药产业规模以上企业数量、企业孵化器数量、新增专利数、自然科学基金立项投入总额、非自然科学基金立项数量、产学研合作项数量六大指标数据。采用灰色关联分析法,将所得数据进行建模并求解,得出这六大指标与粤港澳大湾区生物医药产业主营业务收入的关联度。结果显示,规模以上企业数量与粤港澳大湾区生物医药产业主营业务收入的关联度最高,其次为自然科学基金立项投入总额,再次为产学研合作项数量,非自然科学基金立项数量位列第四,企业孵化器数量、新增专利数分别位列第五、第六。因此,谋求粤港澳大湾区生物医药产业的进一步发展应着重从提高规模以上企业数量、重视自然科学基金投入、加强政产学研合作3个层面入手。

Study on the Benefits of Biomedical Industry in the Guangdong-Hong Kong-Macao Greater Bay Area Based on Grey Comprehensive Correlation Analysis

Biomedical industry is the third largest industry in China’s pharmaceutical manufacturing industry and also one of the emerging high-tech industries supported by Guangdong-Hong Kong-Macao Greater Bay Area. It is necessary to further guide the construction planning of biomedical industry in Guangdong-Hong Kong-Macao Greater Bay Area by analyzing the relationship between the main business income and various indicators. The grey comprehensive correlation analysis method is an important tool to explore the correlation degree between indicators. Through various authoritative channels, six index data are obtained, including the number of enterprises above designated size, business incubators, new patents, projects approved by non NSFC, industry university research cooperation projects and the total investment of projects approved by NSFC. The grey relational analysis method is used to model and solve the data and the correlation degree between the six indicators and the main business income of Guangdong-Hong Kong-Macao Greater Bay Area biomedical industry is obtained. The results show that the number of enterprises above designated size has the highest correlation with the main business income of the biomedical industry in Guangdong-Hong Kong-Macao Greater Bay Area, followed by the total investment of NSFC funded projects and the number of industry university research cooperation projects. The number of non NSFC funded projects ranked fourth, the number of business incubators and the number of new patents ranked fifth and sixth, respectively. Therefore, in order to further develop the biomedical industry in Guangdong-Hong Kong-Macao Greater Bay Area, three aspects should be focused on, increasing the number of enterprises above designated size, attaching importance to the investment of NSFC funded projects and strengthening the cooperation of industry.